Alexey Eliseev

Alexey Eliseev is a highly accomplished professional in the pharmaceutical industry, currently serving as the Chief Business Officer at MYR Pharmaceuticals.1 He brings extensive experience and expertise to his role, with a background that spans business development, technology, and medicinal chemistry.

Education and Academic Background

Eliseev's academic credentials are impressive:

• MBA from MIT Sloan School of Management (2004-2005)1
• PhD in Philosophy and Chemistry from Lomonosov Moscow State University (1987-1991)1
• Bachelor of Science degree (1987)1

Prior to his career in the pharmaceutical industry, Eliseev held academic positions, including:

• Postdoctoral fellow at Emory University
• Alexander Von Humboldt Postdoctoral Fellow at Saarland University

Professional Experience

Eliseev's career highlights include:

• Chief Business Officer at MYR Pharmaceuticals1
• Founder and Chief Executive Officer at Mirimmune

His expertise has been crucial in advancing MYR Pharma's projects, including the development of Myrcludex B, a treatment for chronic hepatitis delta.4 Under his leadership, MYR Pharma has achieved significant milestones, such as completing clinical trials and receiving Breakthrough Therapy Designation from the US FDA for their lead compound.45

Location and Contact

Alexey Eliseev is based in the United States, with sources indicating his location as either Brighton or Brookline, Massachusetts.12 His LinkedIn profile, with the username alexey-eliseev-aa6190, shows that he has over 500 connections on the professional networking platform.2

Eliseev's role at MYR Pharma involves key responsibilities in business development and strategic decision-making, contributing to the company's growth and success in developing innovative pharmaceutical solutions.3